Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Surya Semesta Internusa Tbk. (SSIA) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Surya Semesta Internusa Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Surya Semesta Internusa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Surya Semesta Internusa Tbk. trades at Rp1,540 (market cap 7.03T, 12.74M 24h volume). The key difference: Surya Semesta Internusa Tbk. is far larger — about 22.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Surya Semesta Internusa Tbk. is more actively traded (12.74M versus 963.6K). Which is the better fit depends on your goals.

DGNSSSIA
Market Cap
310.75B7.03T
Volume
963.6K12.74M
Lot
9.64K127.35K
Turnover
217.67M19.78B
Average Price
225.891,553.28
Value
217.67M19.78B
Indicative Equilibrium Price
2261,540
Indicative Equilibrium Volume
1K3.16K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
SSIA
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Surya Semesta Internusa Tbk.

PT. Surya Semesta Internusa Tbk (formerly known as PT. Multi Investment Ltd.) was established based on notarial deed No. 37 dated June 15, 1971 of Umi Sutamto, S.H., notary in Jakarta. It is a publicly-listed company engaged in investment in the shares of subsidiaries that develop and manage industrial and real estate, provide construction services, manufacture and market pre-cast and pre-stressed concrete and own hotels.

Read more on SSIA